Drug profile · INN
influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated)
CELVAPAN
influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated) (CELVAPAN) is a biological vaccine - induces immune response.
EMA: withdrawn Antiinfectives for systemic use (J07) J07BB01
Patents linked 0
Pipeline programs 18
News articles 0
Drug details — influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 18
- Data quality
- 0.83
Quick answer
influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated) (CELVAPAN) is a biological vaccine - induces immune response.
Key facts
INN influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated)
Brand CELVAPAN
Mechanism Biological vaccine - induces immune response
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BB01
Mechanism of action
Biological vaccine - induces immune response
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated)?
influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated) (CELVAPAN) is a biological vaccine - induces immune response.
What is the brand name for influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated)?
CELVAPAN is a marketed brand name for influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated). Check FDA Drugs@FDA for the current US label holder and prescribing information.